diphenylamine has been researched along with Astrocytoma, Grade IV in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdul, UK; Brahm, C; Heukelom, S; Honeywell, R; Houweling, M; Koken, PW; Lagerweij, T; Noske, D; Peters, GJ; Sminia, P; Verheul, H; Wedekind, LE; Westerman, BA; Wurdinger, T | 1 |
| Berger, MS; Fenster, T; Ilkhanizadeh, S; Jakobsson, J; Jandial, R; Martinez, M; Masic, S; Nicolaides, TP; Persson, AI; Petri, R; Sabelström, H; Sacheva, R; Saxena, S; Schmidt, C; Shchors, K; Snyder, EY; Weiss, WA; Yuan, E | 1 |
| Chen, Z; Diao, Y; Hou, J; Li, W; Wu, Y; Yang, Z; Zhang, L | 1 |
| Beelen, P; Carcione, C; Carcione, J; Entersz, I; Foty, RA; Jia, D; Lin, H; Liu, L; Mahtabfar, A; Shannon, S; Shreiber, D; Vaca, C; Weaver, M; Yu, M; Zahn, JD | 1 |
4 other study(ies) available for diphenylamine and Astrocytoma, Grade IV
| Article | Year |
|---|---|
Radio-sensitizing effect of MEK inhibition in glioblastoma in vitro and in vivo.
Topics: Animals; Benzamides; Cell Line, Tumor; Diphenylamine; Glioblastoma; Mice; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors | 2023 |
Driving Neuronal Differentiation through Reversal of an ERK1/2-miR-124-SOX9 Axis Abrogates Glioblastoma Aggressiveness.
Topics: Animals; Astrocytoma; Benzamides; Brain Neoplasms; Cell Differentiation; Cell Line, Tumor; Cell Survival; Diphenylamine; Disease Progression; Female; Glioblastoma; Humans; Male; MAP Kinase Signaling System; Mice, Nude; MicroRNAs; Neoplasm Invasiveness; Neoplastic Stem Cells; Neurogenesis; Neurons; Phenotype; Protein Kinase Inhibitors; Radiation Tolerance; SOX9 Transcription Factor | 2019 |
RGD peptide conjugation results in enhanced antitumor activity of PD0325901 against glioblastoma by both tumor-targeting delivery and combination therapy.
Topics: Animals; Antineoplastic Agents; Benzamides; Cell Proliferation; Central Nervous System Neoplasms; Diphenylamine; Drug Delivery Systems; Drug Liberation; Drug Synergism; Female; Glioblastoma; Humans; MAP Kinase Kinase 1; MAP Kinase Kinase 2; Mice; Mice, Inbred BALB C; Oligopeptides; Xenograft Model Antitumor Assays | 2016 |
Inhibition of glioblastoma dispersal by the MEK inhibitor PD0325901.
Topics: Actins; Benzamides; Cell Adhesion; Cell Culture Techniques; Cell Line, Tumor; Cell Movement; Cell Proliferation; Diphenylamine; Extracellular Signal-Regulated MAP Kinases; Glioblastoma; Humans; MAP Kinase Signaling System; Microscopy, Confocal; Phosphorylation; Spheroids, Cellular | 2017 |